PIVOT PATH NAMES MUKTA ARORA AS INDEPENDENT DIRECTOR

Pivot Path has appointed Mukta Arora as Independent Director. Board-level moves in pharma signal 2 things: governance tightening and leadership depth being tested.

For GCC professionals in life sciences ops, supply chain, or regulatory—watch how indie directors reshape vendor strategy and compliance frameworks. We track 1,800+ GCCs; pharma remains a top 5 sector for shared services expansion.

📌 Independent directors often push cost discipline and process standardization—exactly what drives GCC mandate expansion.

Has your pharma GCC seen board-level changes ripple into your team's priorities?

Source: Pivot Path appoints Mukta Arora as Independent Director - Express Pharma

#pharma #governance #GCC #leadership #GCCERA